Bark, Inc. (BARK) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Retail / Consumer Discretionary · as of Sep 25, 2026
Bark, Inc. (BARK)
A forensic read on Bark, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Distress
Financial health
-6.7
Distress distance
Clean
Earnings quality
4
Forensic signals
-54.2%
ROE
-18.5%
Revenue growth
The financial-health reading above compares this company's equity at BOOK value, not at what the market currently pays for it — this free snapshot doesn't pull live market data. Treat it as a rough read, not the final word.
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Bark, Inc. earns an F (Poor — capital at risk) forensic quality grade, and its balance-sheet distress test reads -6.7, placing it in the Distress zone (based on book value, not market value, since this free snapshot doesn't pull live market data — treat this zone as a rough read, not the final word). 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-37.2%
FY2026
Return on invested capital.Return on invested capital is -37.2% in the latest fiscal year, against -36.8% in FY2024, having run between -37.2% and -32.6% across FY2024–FY2026 with no direction held. After-tax operating profit was ($36M) in FY2024 and ($32M) in FY2026, with operating income at -9.3% of revenue in FY2024, -7.3% in FY2025 and -10.2% in FY2026. The capital base behind it came down -13% across FY2024–FY2026, from $98M to $85M, so this is a return struck on a smaller base rather than a record of money put to work.
FCF ($27M)
FY2026
Shareholder returns.Returned $2M to shareholders (buybacks + dividends) in FY2026, but free cash flow was ($27M) after capex — there was no free cash flow to fund the payout from at all, and operating cash flow itself was negative or zero that year too. The entire return is coming from debt or cash reserves, not cash the business itself generated — a harder case than returns merely running ahead of free cash flow, since here there was none to run ahead of.
11d DSO
FY2025→FY2026
Receivables vs revenue.Days sales outstanding moved from 7 to 11 days FY2025→FY2026 (receivables +30% vs revenue -18%). Receivables are creeping up relative to sales. Across FY2024–FY2026 the day count ran 6 → 7 → 11 days, so the latest reading sits on top of a record that was flat or falling before it — one year's move, not a direction the business has been travelling in. Deferred revenue was roughly flat (+5%) over the same period, which doesn't corroborate a benign upfront-billing explanation for the receivables build. Measured against the same quarter twelve months earlier — like-for-like on the calendar, so an ordinary seasonal build cannot produce it — receivables took longer to collect in 4 consecutive quarters (Sep 2025 +2, Dec 2025 +3, Mar 2026 +5, Jun 2026 +17 days). In the latest of them the receivable balance grew +175% against sales -23%, so more of a quarter's billings were still outstanding at the period end than a year earlier — money the company has recognized and not yet been paid. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2025's opening balance is on file, but across the 3 fiscal years read here (FY2024–FY2026) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.
Key fundamentals
Latest Revenue$394.8M
Revenue Growth YoY-18.5%
Revenue CAGR (2yr)-10.3%
Net Margin-9.9%
Free Cash Flow-$26.6M
Return on Equity-54.2%
Debt / Equity0.00x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Bark, Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 25, 2026. Forensic signals flag probability, not certainty.
195d
FY2025→FY2026
Inventory days.Days inventory outstanding moved from 173 to 195 FY2025→FY2026 (against cost of goods sold; inventory -14% vs -16% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.